# Phase II Study of HAIC Using Cisplatin,Leucovorin and 5-Fluorouracil

> **NCT02987699** · PHASE2 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 54 (estimated)

## Conditions studied

- HepatoCellular Carcinoma

## Interventions

- **DRUG:** 5-Fu, oxaliplatin , leucovorin
- **DRUG:** 5-Fu, oxaliplatin , leucovorin
- **DRUG:** 5-Fu, oxaliplatin , leucovorin

## Key facts

- **NCT ID:** NCT02987699
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11
- **Primary completion:** 2017-04
- **Final completion:** 2017-05
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2016-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02987699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02987699, "Phase II Study of HAIC Using Cisplatin,Leucovorin and 5-Fluorouracil". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02987699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*